Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault A, Nguyen T, Frenette C, Kelly M, Vibien A, Brassard P, Fenn S, Dewar K, Hudson TJ, Horn R, René P, Monczak Y, Dascal A: A predominantly clonal multi-institutional outbreak of clostridium difficile–associated diarrhea with high morbidity and mortality. N Engl J Med. 2005, 353: 2442-2449. 10.1056/NEJMoa051639.http://dx.doi.org/10.1056/NEJMoa051639,
Article
CAS
PubMed
Google Scholar
McDonald LC, Killgore GE, Thompson A, Owens RC, Kazakova SV, Sambol SP, Johnson S, Gerding DN: An epidemic, toxin gene–variant strain of clostridium difficile. N Engl J Med. 2005, 353: 2433-2441. 10.1056/NEJMoa051590.http://dx.doi.org/10.1056/NEJMoa051590,
Article
CAS
PubMed
Google Scholar
Muto CA, Pokrywka M, Shutt K, Mendelsohn AB, Nouri K, Posey K, Roberts T, Croyle K, Krystofiak S, Patel‐Brown S, Pasculle AW, Paterson DL, Saul M, Harrison LH:A large outbreak of clostridium difficile‐associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone Use •. Infect Control Hosp Epidemiol. 2005, 26: 273-280. 10.1086/502539.http://dx.doi.org/10.1086/502539,
Article
PubMed
Google Scholar
Hensgens MP, Goorhuis A, Notermans DW, van Benthem BH, Kuijper EJ: Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands. Euro Surveill. 2009, 14: 19402-
PubMed
Google Scholar
Bauer, M. P., D. W. Notermans, B. H. van Benthem, J. S. Brazier, M. H. Wilcox, M. Rupnik, D. L. Monnet, J. T. van Dissel, E. J. Kuijper, and ECDIS Study Group: Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011, 377: 63-73. 10.1016/S0140-6736(10)61266-4.
Article
Google Scholar
Goorhuis A, Bakker D, Corver J, Debast SB, Harmanus C, Notermans DW, Bergwerff AA, Dekker FW, Kuijper EJ: Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis. 2008, 47: 1162-1170. 10.1086/592257.
Article
CAS
PubMed
Google Scholar
Debast SB, van Leengoed LA, Goorhuis A, Harmanus C, Kuijper EJ, Bergwerff AA: Clostridium difficile PCR ribotype 078 toxinotype V found in diarrhoeal pigs identical to isolates from affected humans. Environ Microbiol. 2009, 11: 505-511. 10.1111/j.1462-2920.2008.01790.x.
Article
CAS
PubMed
Google Scholar
Keel K, Brazier JS, Post KW, Weese S, Songer JG: Prevalence of PCR Ribotypes among Clostridium difficile Isolates from Pigs, Calves, and Other Species▿. J Clin Microbiol. 2007, 45: 1963-1964. 10.1128/JCM.00224-07.
Article
PubMed Central
CAS
PubMed
Google Scholar
Keessen EC, Hopman NE, van Leengoed LA, van Asten AJ, Hermanus C, Kuijper EJ, Lipman LJ: Evaluation of four different diagnostic tests to detect Clostridium difficile in piglets. J Clin Microbiol. 2011, 49: 1816-1821. 10.1128/JCM.00242-11.
Article
PubMed Central
CAS
PubMed
Google Scholar
Songer JG, Anderson MA: Clostridium difficile: an important pathogen of food animals. Anaerobe. 2006, 12: 1-4. 10.1016/j.anaerobe.2005.09.001.
Article
CAS
PubMed
Google Scholar
Songer JG: The emergence of Clostridium difficile as a pathogen of food animals. Anim Health Res Rev. 2004, 5: 321-326. 10.1079/AHR200492.
Article
PubMed
Google Scholar
Anderson MA, Songer JG: Evaluation of two enzyme immunoassays for detection of Clostridium difficile toxins A and B in swine. Vet Microbiol. 2008, 128: 204-206. 10.1016/j.vetmic.2007.09.022.
Article
CAS
PubMed
Google Scholar
Bartlett JG, Gerding DN: Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis. 2008, 46 (Suppl 1): S12-8. 10.1086/521863.
Article
PubMed
Google Scholar
Eucast2. Anonymous. 2011,http://217.70.33.99/Eucast2/SearchController/search.jsp?action=performSearch%26;BeginIndex=0%26;Micdif=mic%26;NumberIndex=50%26;Antib=−1%26;Specium=222,
Hecht DW, Citron DM, Dzink-Fox J, Gregory WW, Jacobus NV, Jenkins SG, Rosenblatt JE, Schuetz AN, Wexler H: Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard - eighth edition. 2012, 32: M11-A8.
Google Scholar
Spigaglia P, Mastrantonio P: Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol. 2002, 40: 3470-3475. 10.1128/JCM.40.9.3470-3475.2002.
Article
PubMed Central
CAS
PubMed
Google Scholar
Spigaglia P, Barbanti F, Mastrantonio P: Detection of a genetic linkage between genes coding for resistance to tetracycline and erythromycin in Clostridium difficile. Microb Drug Resist. 2007, 13: 90-95. 10.1089/mdr.2007.723.
Article
CAS
PubMed
Google Scholar
Spigaglia P, Mastrantonio P: Comparative analysis of Clostridium difficile clinical isolates belonging to different genetic lineages and time periods. J Med Microbiol. 2004, 53: 1129-1136. 10.1099/jmm.0.45682-0.
Article
CAS
PubMed
Google Scholar
Spigaglia P, Barbanti F, Louie T, Barbut F, Mastrantonio P: Molecular analysis of the gyrA and gyrB quinolone resistance-determining regions of fluoroquinolone-resistant Clostridium difficile mutants selected in vitro. Antimicrob Agents Chemother. 2009, 53: 2463-2468. 10.1128/AAC.01252-08.
Article
PubMed Central
CAS
PubMed
Google Scholar
Spigaglia, P., F. Barbanti, P. Mastrantonio, and European Study Group on Clostridium difficile (ESGCD): Multidrug resistance in European Clostridium difficile clinical isolates. J Antimicrob Chemother. 2011, 66: 2227-2234. 10.1093/jac/dkr292.
Article
Google Scholar
Solomon K, Fanning S, McDermott S, Murray S, Scott L, Martin A, Skally M, Burns K, Kuijper E, Fitzpatrick F, Fenelon L, Kyne L: PCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates. J Antimicrob Chemother. 2011, 66: 1976-1982. 10.1093/jac/dkr275.
Article
CAS
PubMed
Google Scholar
Grave K, Torren-Edo J, Mackay D: Comparison of the sales of veterinary antibacterial agents between 10 European countries. J Antimicrob Chemother. 2010, 65: 2037-2040. 10.1093/jac/dkq247.
Article
CAS
PubMed
Google Scholar
Coenen S, Adriaenssens N, Versporten A, Muller A, Minalu G, Faes C, Vankerckhoven V, Aerts M, Hens N, Molenberghs G, Goossens H, Project Group ESAC: European Surveillance of Antimicrobial Consumption (ESAC): outpatient use of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in Europe (1997–2009). J Antimicrob Chemother. 2011, 66 (Suppl 6): vi57-70. 10.1093/jac/dkr458.
Article
CAS
PubMed
Google Scholar
Anonymous Antibiotic use - Wageningen UR - LEI. 2011,http://www.maran.wur.nl/,
Norman KN, Harvey RB, Scott HM, Hume ME, Andrews K, Brawley AD: Varied prevalence of Clostridium difficile in an integrated swine operation. Anaerobe. 2009, 15: 256-260. 10.1016/j.anaerobe.2009.09.006.
Article
CAS
PubMed
Google Scholar
Bakker D, Corver J, Harmanus C, Goorhuis A, Keessen EC, Fawley WN, Wilcox MH, Kuijper EJ: Relatedness of human and animal Clostridium difficile PCR ribotype 078 isolates determined on the basis of multilocus variable-number tandem-repeat analysis and tetracycline resistance. J Clin Microbiol. 2010, 48: 3744-3749. 10.1128/JCM.01171-10.
Article
PubMed Central
CAS
PubMed
Google Scholar
Jhung MA, Thompson AD, Killgore GE, Zukowski WE, Songer G, Warny M, Johnson S, Gerding DN, McDonald LC, Limbago BM: Toxinotype V Clostridium difficile in humans and food animals. Emerg Infect Dis. 2008, 14: 1039-1045. 10.3201/eid1407.071641.
Article
PubMed Central
CAS
PubMed
Google Scholar
Stabler RA, Gerding DN, Songer JG, Drudy D, Brazier JS, Trinh HT, Witney AA, Hinds J, Wren BW: Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains. J Bacteriol. 2006, 188: 7297-7305. 10.1128/JB.00664-06.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hunter PA, Dawson S, French GL, Goossens H, Hawkey PM, Kuijper EJ, Nathwani D, Taylor DJ, Teale CJ, Warren RE, Wilcox MH, Woodford N, Wulf MW, Piddock LJ: Antimicrobial-resistant pathogens in animals and man: prescribing, practices and policies. J Antimicrob Chemother. 2010, 65 (Suppl 1): i3-17. 10.1093/jac/dkp433.
Article
CAS
PubMed
Google Scholar
Spigaglia P, Barbanti F, Mastrantonio P, Brazier JS, Barbut F, Delmee M, Kuijper E, Poxton IR, European Study Group on Clostridium difficile (ESGCD): Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe. J Med Microbiol. 2008, 57: 784-789. 10.1099/jmm.0.47738-0.
Article
CAS
PubMed
Google Scholar
Drudy D, Kyne L, O’Mahony R, Fanning S: gyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027. Emerg Infect Dis. 2007, 13: 504-505. 10.3201/eid1303.060771.
Article
PubMed Central
CAS
PubMed
Google Scholar
Spigaglia P, Barbanti F, Mastrantonio P: New variants of the tet(M) gene in Clostridium difficile clinical isolates harbouring Tn916-like elements. J Antimicrob Chemother. 2006, 57: 1205-1209. 10.1093/jac/dkl105.
Article
CAS
PubMed
Google Scholar
Post KW, Songer JG: Antimicrobial susceptibility of Clostridium difficile isolated from neonatal pigs with enteritis. Anaerobe. 2004, 10: 47-50. 10.1016/j.anaerobe.2004.01.003.
Article
CAS
PubMed
Google Scholar